These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18592095)

  • 41. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy.
    Thaman R; Gimeno JR; Reith S; Esteban MT; Limongelli G; Murphy RT; Mist B; McKenna WJ; Elliott PM
    J Am Coll Cardiol; 2004 Jul; 44(2):398-405. PubMed ID: 15261938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of ventricular arrhythmias in the presence of pathological hypertrophy.
    Cosín Aguilar J; Hernandiz Martinez A; Andres Conejos F
    Eur Heart J; 1993 Nov; 14 Suppl J():65-70. PubMed ID: 8281966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats.
    Bhuiyan MS; Shioda N; Fukunaga K
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1606-14. PubMed ID: 17878225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How to estimate left ventricular hypertrophy in hypertensive patients.
    Lovic D; Erdine S; Catakoğlu AB
    Anadolu Kardiyol Derg; 2014 Jun; 14(4):389-95. PubMed ID: 24818777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.
    Kato TS; Noda A; Izawa H; Yamada A; Obata K; Nagata K; Iwase M; Murohara T; Yokota M
    Circulation; 2004 Dec; 110(25):3808-14. PubMed ID: 15583080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy.
    Patel SK; Ramchand J; Crocitti V; Burrell LM
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling.
    Maayah ZH; Takahara S; Alam AS; Ferdaoussi M; Sutendra G; El-Kadi AOS; Mackey JR; Pituskin E; Paterson DI; Dyck JRB
    BMC Cancer; 2020 Aug; 20(1):751. PubMed ID: 32787791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular and signaling mechanisms of cardiac hypertrophy.
    Piano MR
    J Cardiovasc Nurs; 1994 Jul; 8(4):1-26. PubMed ID: 7931462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac remodeling induced by smoking: concepts, relevance, and potential mechanisms.
    Minicucci MF; Azevedo PS; Polegato BF; Paiva SA; Zornoff LA
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):442-7. PubMed ID: 22680625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of hypertrophy: an active biologic process.
    Susic D; Nuñez E; Frohlich ED
    Curr Opin Cardiol; 1995 Sep; 10(5):466-72. PubMed ID: 7496054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left Ventricular Hypertrophy: Roles of Mitochondria CYP1B1 and Melatonergic Pathways in Co-Ordinating Wider Pathophysiology.
    Anderson G; Mazzoccoli G
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical animal model of ventricular hypertrophy.
    Marano G; Ferrari AU
    Methods Mol Med; 2007; 139():95-104. PubMed ID: 18287666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Research progress of Chinese herbal drugs in regulating ventricular remodeling by the pathway of nitric oxide].
    DU J; Chen CX
    Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):702-6. PubMed ID: 17997951
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclin D in left ventricle hypertrophy.
    Busk PK; Hinrichsen R
    Cell Cycle; 2003; 2(2):91-5. PubMed ID: 12695654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular and cellular mechanisms of myocardial remodeling.
    Maytin M; Colucci WS
    J Nucl Cardiol; 2002; 9(3):319-27. PubMed ID: 12032480
    [No Abstract]   [Full Text] [Related]  

  • 56. A new stone for a new path, from "physiology to the bedside".
    Zhang YH; Han J
    Pflugers Arch; 2019 Aug; 471(8):1043-1044. PubMed ID: 31270620
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives.
    Cacciapuoti F
    J Am Soc Hypertens; 2011; 5(6):449-55. PubMed ID: 22015318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aerobic exercise prevents cardiomyocyte damage caused by oxidative stress in early cardiovascular disease by increasing vascularity while L-arginine supplementation prevents it by increasing activation of the enzyme nitric oxide synthase.
    Bertoldi JMCRJ; Kindlovits R; Rocha HNM; Fernandes-Santos C; Gomes JLP; Oliveira EM; Muniz IC; Santos MM; Pereira JF; Rocha NG; Nóbrega ACLD; Medeiros RF
    Braz J Med Biol Res; 2023; 56():e12533. PubMed ID: 37585913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity.
    Loyer X; Dubroca C; Branchereau M; Griffith G; Garcia L; Heymes C
    Biochem Biophys Rep; 2019 Jul; 18():100620. PubMed ID: 30899802
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.